ClariMedClariMed
Recherchen nahtlos fortsetzen
30 Sek mit Email - kein Passwort, kein Formular. Ihr Verlauf bleibt auf jedem Gerät.

Verlauf

Keine Anfragen

EMA2026EN

Imatinib Teva — SmPC (Summary of Product Characteristics)

Zusammenfassung

## 1 1. NAME OF THE MEDICINAL PRODUCT Imatinib Teva 100 mg film‑coated tablets Imatinib Teva 400 mg film‑coated tablets ## 2 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Imatinib Teva 100 mg film‑coated tablets Each film‑coated tablet contains 100 mg of imatinib (as mesilate).   Imatinib Teva 400 mg film‑coated tablets Each film‑coated tablet contains 400 mg of imatinib (as mesilate).   For the full list of excipients, see section 6.1. ## 3 3. PHARMACEUTICAL FORM Film‑coated tablet.  

Kerninformationen

o equal doses.   Imatinib Teva 400 mg film‑coated tablets Dark yellow to brownish orange oblong film‑coated tablets with a score line on one side. The tablet is debossed with “IT” and “4” at each side of the score line. The length of the film-coated tablet is approximately 20 mm and the width is ...
e or blast crisis. adult and paediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukaemia (Ph+ ALL) integrated with chemotherapy. adult patients with relapsed or refractory Ph+ ALL as monotherapy. adult patients with myelodysplastic/myeloproliferative di...
al tumours (GIST). the adjuvant treatment of adult patients who are at significant risk of relapse following resection of Kit (CD117)-positive GIST. Patients who have a low or very low risk of recurrence should not receive adjuvant treatment. the treatment of adult patients with unresectable derma...
Originaldokument ansehen

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen

Verwandte Leitlinien